Literature DB >> 24613456

Studies on the antiproliferative effects of tropolone derivatives in Jurkat T-lymphocyte cells.

Sophia N Ononye1, Michael D Vanheyst1, Charles Giardina1, Dennis L Wright1, Amy C Anderson2.   

Abstract

Thujaplicins are tropolone-derived natural products with antiproliferative properties. We recently reported that certain tropolones potently and selectively target histone deacetylases (HDAC) and inhibit the growth of hematological cell lines. Here, we investigated the mechanisms by which these compounds exert their antiproliferative activity in comparison with the pan-selective HDAC inhibitor, vorinostat, using Jurkat T-cell leukemia cells. The tropolones appear to work through a mechanism distinct from vorinostat. These studies suggest that tropolone derivatives may serve as selective epigenetic modulators of hematological cells with potential applications as anti-leukemic or anti-inflammatory agents.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HDAC inhibitor; Leukemia; Natural product; Tropolone; Vorinostat

Mesh:

Substances:

Year:  2014        PMID: 24613456      PMCID: PMC4011186          DOI: 10.1016/j.bmc.2014.02.018

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  32 in total

Review 1.  Histone deacetylase inhibitors in the treatment of lymphoma.

Authors:  Manuela Lemoine; Anas Younes
Journal:  Discov Med       Date:  2010-11       Impact factor: 2.970

2.  Tropolones as lead-like natural products: the development of potent and selective histone deacetylase inhibitors.

Authors:  Sophia N Ononye; Michael D VanHeyst; E Zachary Oblak; Wangda Zhou; Mohamed Ammar; Amy C Anderson; Dennis L Wright
Journal:  ACS Med Chem Lett       Date:  2013-06-10       Impact factor: 4.345

Review 3.  Histone deacetylases (HDACs): characterization of the classical HDAC family.

Authors:  Annemieke J M de Ruijter; Albert H van Gennip; Huib N Caron; Stephan Kemp; André B P van Kuilenburg
Journal:  Biochem J       Date:  2003-03-15       Impact factor: 3.857

4.  New method to detect histone acetylation levels by flow cytometry.

Authors:  Simona Ronzoni; Mario Faretta; Marco Ballarini; Piergiuseppe Pelicci; Saverio Minucci
Journal:  Cytometry A       Date:  2005-07       Impact factor: 4.355

Review 5.  Emerging roles of caspase-3 in apoptosis.

Authors:  A G Porter; R U Jänicke
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

6.  Toward an HDAC6 inhibitor: synthesis and conformational analysis of cyclic hexapeptide hydroxamic acid designed from alpha-tubulin sequence.

Authors:  Binoy Jose; Shinji Okamura; Tamaki Kato; Norikazu Nishino; Yuko Sumida; Minoru Yoshida
Journal:  Bioorg Med Chem       Date:  2004-03-15       Impact factor: 3.641

Review 7.  Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer.

Authors:  Sophia N Ononye; Michael van Heyst; Eric M Falcone; Amy C Anderson; Dennis L Wright
Journal:  Pharm Pat Anal       Date:  2012-05

8.  Transcriptional modulation using HDACi depsipeptide promotes immune cell-mediated tumor destruction of murine B16 melanoma.

Authors:  Takashi Murakami; Atsuko Sato; Nicole A L Chun; Mayumi Hara; Yuki Naito; Yukiko Kobayashi; Yasuhiko Kano; Mamitaro Ohtsuki; Yusuke Furukawa; Eiji Kobayashi
Journal:  J Invest Dermatol       Date:  2008-01-10       Impact factor: 8.551

9.  HDAC2 negatively regulates memory formation and synaptic plasticity.

Authors:  Ji-Song Guan; Stephen J Haggarty; Emanuela Giacometti; Jan-Hermen Dannenberg; Nadine Joseph; Jun Gao; Thomas J F Nieland; Ying Zhou; Xinyu Wang; Ralph Mazitschek; James E Bradner; Ronald A DePinho; Rudolf Jaenisch; Li-Huei Tsai
Journal:  Nature       Date:  2009-05-07       Impact factor: 49.962

Review 10.  Rationale for possible targeting of histone deacetylase signaling in cancer diseases with a special reference to pancreatic cancer.

Authors:  Mehdi Ouaïssi; Urs Giger; Igor Sielezneff; Nicolas Pirrò; Bernard Sastre; Ali Ouaissi
Journal:  J Biomed Biotechnol       Date:  2010-10-25
View more
  2 in total

1.  Tropolone-induced effects on the unfolded protein response pathway and apoptosis in multiple myeloma cells are dependent on iron.

Authors:  Staci L Haney; Michelle L Varney; Hannah R Safranek; Yashpal S Chhonker; Narendran G-Dayanandan; Geoffrey Talmon; Daryl J Murry; Andrew J Wiemer; Dennis L Wright; Sarah A Holstein
Journal:  Leuk Res       Date:  2018-12-21       Impact factor: 3.156

2.  Novel tropolones induce the unfolded protein response pathway and apoptosis in multiple myeloma cells.

Authors:  Staci L Haney; Cheryl Allen; Michelle L Varney; Kaitlyn M Dykstra; Eric R Falcone; Sean H Colligan; Qiang Hu; Alyssa M Aldridge; Dennis L Wright; Andrew J Wiemer; Sarah A Holstein
Journal:  Oncotarget       Date:  2017-06-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.